Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Covariance adjustment for batch effect in gene expression data.

Lee JA, Dobbin KK, Ahn J.

Stat Med. 2014 Jul 10;33(15):2681-95. doi: 10.1002/sim.6157. Epub 2014 Mar 28.

PMID:
24687561
[PubMed - in process]
2.

Statistical design and evaluation of biomarker studies.

Dobbin KK.

Methods Mol Biol. 2014;1102:667-77. doi: 10.1007/978-1-62703-727-3_36. Review.

PMID:
24259005
[PubMed - indexed for MEDLINE]
3.

Health and personal resources in older patients with cancer undergoing chemotherapy.

Robb C, Lee A, Jacobsen P, Dobbin KK, Extermann M.

J Geriatr Oncol. 2013 Apr;4(2):166-73. doi: 10.1016/j.jgo.2012.12.002. Epub 2013 Jan 8.

PMID:
24071541
[PubMed - indexed for MEDLINE]
4.

Sample size requirements for training high-dimensional risk predictors.

Dobbin KK, Song X.

Biostatistics. 2013 Sep;14(4):639-52. doi: 10.1093/biostatistics/kxt022. Epub 2013 Jul 19.

PMID:
23873895
[PubMed - indexed for MEDLINE]
5.

Lower confidence bounds for prediction accuracy in high dimensions via AROHIL Monte Carlo.

Dobbin KK, Cooke S.

Bioinformatics. 2011 Nov 15;27(22):3129-34. doi: 10.1093/bioinformatics/btr542. Epub 2011 Sep 28.

PMID:
21965820
[PubMed - indexed for MEDLINE]
Free Article
6.

Optimally splitting cases for training and testing high dimensional classifiers.

Dobbin KK, Simon RM.

BMC Med Genomics. 2011 Apr 8;4:31. doi: 10.1186/1755-8794-4-31.

PMID:
21477282
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.

Harvey RC, Mullighan CG, Wang X, Dobbin KK, Davidson GS, Bedrick EJ, Chen IM, Atlas SR, Kang H, Ar K, Wilson CS, Wharton W, Murphy M, Devidas M, Carroll AJ, Borowitz MJ, Bowman WP, Downing JR, Relling M, Yang J, Bhojwani D, Carroll WL, Camitta B, Reaman GH, Smith M, Hunger SP, Willman CL.

Blood. 2010 Dec 2;116(23):4874-84. doi: 10.1182/blood-2009-08-239681. Epub 2010 Aug 10.

PMID:
20699438
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.

Dancey JE, Dobbin KK, Groshen S, Jessup JM, Hruszkewycz AH, Koehler M, Parchment R, Ratain MJ, Shankar LK, Stadler WM, True LD, Gravell A, Grever MR; Biomarkers Task Force of the NCI Investigational Drug Steering Committee.

Clin Cancer Res. 2010 Mar 15;16(6):1745-55. doi: 10.1158/1078-0432.CCR-09-2167. Epub 2010 Mar 9.

PMID:
20215558
[PubMed - indexed for MEDLINE]
Free Article
9.

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.

Harvey RC, Mullighan CG, Chen IM, Wharton W, Mikhail FM, Carroll AJ, Kang H, Liu W, Dobbin KK, Smith MA, Carroll WL, Devidas M, Bowman WP, Camitta BM, Reaman GH, Hunger SP, Downing JR, Willman CL.

Blood. 2010 Jul 1;115(26):5312-21. doi: 10.1182/blood-2009-09-245944. Epub 2010 Feb 4.

PMID:
20139093
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A method for constructing a confidence bound for the actual error rate of a prediction rule in high dimensions.

Dobbin KK.

Biostatistics. 2009 Apr;10(2):282-96. doi: 10.1093/biostatistics/kxn035. Epub 2008 Nov 27.

PMID:
19039030
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.

Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S, Jurisica I, Giordano TJ, Misek DE, Chang AC, Zhu CQ, Strumpf D, Hanash S, Shepherd FA, Ding K, Seymour L, Naoki K, Pennell N, Weir B, Verhaak R, Ladd-Acosta C, Golub T, Gruidl M, Sharma A, Szoke J, Zakowski M, Rusch V, Kris M, Viale A, Motoi N, Travis W, Conley B, Seshan VE, Meyerson M, Kuick R, Dobbin KK, Lively T, Jacobson JW, Beer DG.

Nat Med. 2008 Aug;14(8):822-7. doi: 10.1038/nm.1790. Epub 2008 Jul 20.

PMID:
18641660
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

How large a training set is needed to develop a classifier for microarray data?

Dobbin KK, Zhao Y, Simon RM.

Clin Cancer Res. 2008 Jan 1;14(1):108-14. doi: 10.1158/1078-0432.CCR-07-0443.

PMID:
18172259
[PubMed - indexed for MEDLINE]
Free Article
13.

Five-gene signature in non-small-cell lung cancer.

Dobbin KK.

N Engl J Med. 2007 Apr 12;356(15):1582; author reply 1583. No abstract available.

PMID:
17436430
[PubMed - indexed for MEDLINE]
14.

Sample size planning for developing classifiers using high-dimensional DNA microarray data.

Dobbin KK, Simon RM.

Biostatistics. 2007 Jan;8(1):101-17. Epub 2006 Apr 13.

PMID:
16613833
[PubMed - indexed for MEDLINE]
Free Article
15.

Comment on 'Evaluation of the gene-specific dye bias in cDNA microarray experiments'.

Dobbin KK, Shih JH, Simon RM.

Bioinformatics. 2005 Jun 15;21(12):2803-4. Epub 2005 Apr 7. No abstract available.

PMID:
15817695
[PubMed - indexed for MEDLINE]
Free Article
16.

Characterizing dye bias in microarray experiments.

Dobbin KK, Kawasaki ES, Petersen DW, Simon RM.

Bioinformatics. 2005 May 15;21(10):2430-7. Epub 2005 Mar 17.

PMID:
15774555
[PubMed - indexed for MEDLINE]
Free Article
17.

Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays.

Dobbin KK, Beer DG, Meyerson M, Yeatman TJ, Gerald WL, Jacobson JW, Conley B, Buetow KH, Heiskanen M, Simon RM, Minna JD, Girard L, Misek DE, Taylor JM, Hanash S, Naoki K, Hayes DN, Ladd-Acosta C, Enkemann SA, Viale A, Giordano TJ.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):565-72.

PMID:
15701842
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk